The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation (Q26778369)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation	scientific article

Statements

scholarly article

0 references

systematic review

1 reference

based on heuristic

inferred from title

The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation (English)

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Amanda Nicholson

1

0 references

James Mahon

2

0 references

Angela Boland

3

0 references

Sophie Beale

4

0 references

Kerry Dwan

5

0 references

Nigel Fleeman

6

0 references

Juliet Hockenhull

7

0 references

Yenal Dundar

8

0 references

language of work or name

0 references

publication date

October 2015

0 references

Health Technology Assessment

0 references

19

0 references

87

0 references

i-xxxi, 1-191

0 references

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of a breast cancer screening programme on quality-adjusted life-years

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Chapter 11: challenges in and principles for conducting systematic reviews of genetic tests used as predictive indicators

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

PCA3 in the detection and management of early prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of magnetic resonance imaging in the detection of prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels: a meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of prostate cancer in unscreened men: external validation of a risk calculator

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The Optimal Rebiopsy Prostatic Scheme Depends on Patient Clinical Characteristics: Results of a Recursive Partitioning Analysis Based on a 24-Core Systematic Scheme

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of prostate cancer: European Association of Urology recommendation

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Accuracy, precision, and reliability of chemical measurements in natural products research

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Appropriate statistical methods are required to assess diagnostic tests for replacement, add-on, and triage

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The roles of multiparametric magnetic resonance imaging, PCA3 and prostate health index-which is the best predictor of prostate cancer after a negative biopsy?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of the performance characteristics of the free prostate-specific antigen test

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Everything you always wanted to know about evaluating prediction models (but were too afraid to ask).

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical judgment versus biomarker prostate cancer gene 3: which is best when determining the need for repeat prostate biopsy?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer gene 3 and multiparametric magnetic resonance can reduce unnecessary biopsies: decision curve analysis to evaluate predictive models

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary hormonal therapy for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of digital rectal examination for prostate cancer detection is modified by obesity

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation analysis of the MSMB gene in familial prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Current perspectives on the Gleason grading of prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life effects of prostate-specific antigen screening.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinical

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal histology of the prostate.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

MRI-ultrasound fusion for guidance of targeted prostate biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen velocity (PSAV): a practical role for PSA?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of Prostate Health Index for prostate cancer detection

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimising repeat prostate biopsy decisions and procedures

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Decision curve analysis: a novel method for evaluating prediction models

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Decision curve analysis: a discussion

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen receptor in prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35?

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-treatment risk stratification of prostate cancer patients: A critical review

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

"Sensitivity" and "specificity" reconsidered: the meaning of these terms in analytical and diagnostic settings

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.3310%2FHTA19870

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.3310/HTA19870

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26778369&oldid=1953529651"